San Raffaele
| Italien | Türkei | Österreich | |
| Stammzellentherapie bei ALS (Amyotrophe Lateralsklerose) | von $40,000 | von $30,000 | von $60,000 |
| Stammzellen Therapie | von $10,000 | von $4,675 | von $8,500 |
| Plasmapherese | von $2,200 | von $1,200 | von $2,000 |
| Therapie mit induzierten pluripotenten Stammzellen | von $32,000 | - | - |
Bookimed erhebt keine zusätzlichen Gebühren für Amyotrophe Lateralsklerose-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Amyotrophe Lateralsklerose einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Amyotrophe Lateralsklerose-Behandlungsreise nie allein.
Riluzole is the only disease-modifying medication routinely reimbursed by the Italian National Health System. Neurologists prescribe it free of charge to prevent nerve cell damage. Other treatments like Edaravone remain available primarily through clinical trials or specialized compassionate use programs.
Bookimed Expert Insight: While Riluzole is standard, Italy excels in experimental access via IRCCS accredited centers. Facilities like San Raffaele manage over 300,000 patients yearly. They combine clinical care with advanced research. Patients often find specialized stem cell protocols here that are unavailable elsewhere. This makes Italy a hub for rare disease research beyond basic prescriptions.
Patient Consensus: Patients value the multidisciplinary support in Milan. They emphasize finding a neurologist who understands early access to experimental therapies.
Italy features top ALS centers concentrated in Milan, Turin, and Rome. These institutions combine neurology, respiratory therapy, and genetics research. San Raffaele and Policlinico Gemelli are primary hubs. They utilize advanced IRCCS-certified research models. Integrated multidisciplinary teams manage most patient care pathways.
Bookimed Expert Insight: Milan serves as the primary hub for neurological research and volume. San Raffaele alone performs over 52,000 operations and sees 300,000 patients yearly. This high volume often leads to earlier access to specialized respiratory protocols. Consider Milan-based clinics if you require immediate integration with advanced ventilation support.
Patient Consensus: Patients emphasize finding a team with a dedicated respiratory therapist. Many note that northern Italian centers offer smoother coordination between nutritionists and neurologists. Consistency with one doctor throughout treatment is highly valued for managing complex symptoms.
Multidisciplinary care is standard in large Italian academic hospitals and specialized ALS centers. These integrated teams include neurologists, respiratory therapists, and nutritionists. While universal in major centers, smaller facilities show lower multidisciplinary integration. Regional programs in Emilia-Romagna and Sardinia mandate hospital-to-home care pathways.
Bookimed Expert Insight: Italian research hospitals like San Raffaele in Milan offer a distinct advantage for rare neurodegenerative conditions. San Raffaele holds IRCCS status from the Italian Ministry of Health for its research-hospital excellence. It manages over 300,000 patients annually and pioneered the first stem cell therapy for specific genetic disorders. Choosing centers with this national research accreditation ensures access to protocols that combine clinical care with scientific advancement.
Patient Consensus: Patients note that seeking care at dedicated centers in Northern Italy provides better access to full teams. They emphasize that while local neurologists prescribe medication, traveling to specialized units is necessary for integrated physical and respiratory therapy.
Patients can access experimental ALS therapies in Italy through clinical trials and compassionate use programs. Leading research hospitals, such as San Raffaele in Milan, conduct advanced research and offer treatments like stem cell therapy. Participation for foreign nationals generally requires a legal residency permit and local tax code.
Bookimed Expert Insight: San Raffaele functions as one of Europe largest research hospitals, serving 300,000 patients annually. Its IRCCS accreditation confirms it combines clinical care with active scientific research. While many private clinics focus on rehabilitation, IRCCS centers are essential for accessing experimental protocols and specialized neurology departments.
Patient Consensus: Patients note that navigating Italian trial paperwork is significantly easier when working with local patient organizations like AISLA. Most report that having a neurology team willing to advocate for compassionate use is vital for success.
Italian law grants patients the legal right to refuse or withdraw life-sustaining ventilation. Law 219/2017 establishes that medical treatments require free, informed consent. This applies even if withdrawal leads to death. Doctors must respect these autonomous decisions to avoid legal liability.
Bookimed Expert Insight: Italian research hospitals like San Raffaele in Milan facilitate complex neurological care. Our data shows these centers combine clinical assistance with active research. Decisions about ventilation often happen within multidisciplinary teams. These teams include neurologists and palliative specialists. This protects patient autonomy in high-volume research settings.
Patient Consensus: Patients find comfort in knowing they can legally document their wishes early. Many emphasize that having a clear plan reduces family stress during later stages.